UMB Bank’s Oramed Pharmaceuticals ORMP Stock Holding History

UMB Bank’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,880	Closed	-$68K	–	1998
2022 Q1	$68K	Sell	7,880 -200	-2%	-$2.05K	﹤0.01%	878
2021 Q4	$116K	Buy	+8,080	New	+$169K	﹤0.01%	778

Other funds holding ORMP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UMB Bank's ORMP Position: Q2 2022 in Review

UMB Bank sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 7,880 shares — an estimated $68K sold.

UMB Bank first reported a position in ORMP in Q4 2021 and held it in 2 quarters. The position peaked at $116K in Q4 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

UMB Bank reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
UMB Bank sold 7,880 Oramed Pharmaceuticals shares in Q2 2022, an estimated $68K.
UMB Bank first reported a position in Oramed Pharmaceuticals in Q4 2021 and held it in 2 quarters.
UMB Bank's Oramed Pharmaceuticals position peaked at $116K in Q4 2021.
88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on UMB Bank's 13F filing for Q2 2022, filed 20 Jul 2022.